Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder
1 clinical trials · Condition
◉ Watch Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder
| Record | Firm | Date |
|---|---|---|
| The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm (NCT03558607) | Seoul National University Hospital | 2018-05-17 |
Track Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder automatically
Every clearance here is in the API, with alerts when new ones post.